N-Acetylaspartate concentrations in the thalami of neuropathic pain patients and healthy comparison subjects measured with (1)H-MRS.

We investigated the absolute concentration of N-acetylaspartate (NAA) in the thalami of neuropathic pain patients and healthy comparison subjects by single-voxel proton magnetic resonance spectroscopy ((1)H-MRS). (1)H-MRS was performed with a 1.5-T MR system on a voxel in the thalamus bilaterally in 9 neuropathic pain patients and 14 healthy control subjects. We measured the absolute concentration of NAA using a linear combination model. The NAA concentration in the thalamus decreased significantly on the contralateral side in seven patients and on the ipsilateral side in two patients, as compared with the mean NAA concentration of the healthy control subjects. The NAA concentrations in two patients who did not respond to standard pain treatments were extremely decreased. Our results using (1)H-MRS suggest that neuropathic pain seems to be associated with an abnormal balance of the neural activity in the thalamus. The NAA concentration of the thalamus may be related to the efficacy of therapy. (1)H-MRS may serve as a useful noninvasive tool for evaluating thalamic neural activity in neuropathic pain patients.

[1]  A. Vania Apkarian,et al.  Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study , 2000, Pain.

[2]  Proton magnetic resonance spectroscopy of the thalamus in chronic complex regional pain syndrome (CRPS) type-1 patients , 2002 .

[3]  B D Ross,et al.  Probable Alzheimer disease: diagnosis with proton MR spectroscopy. , 1995, Radiology.

[4]  J. Maisog,et al.  Pain intensity processing within the human brain: a bilateral, distributed mechanism. , 1999, Journal of neurophysiology.

[5]  Y Yonekura,et al.  Evaluation of brain metabolism in steno-occlusive carotid artery disease by proton MR spectroscopy: a correlative study with oxygen metabolism by PET. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  S. Fukui Evaluation of thalamic neural activity in CRPS type 1 patients by proton MR spectroscopy: a correlative study with rCBF , 2003, Journal of Anesthesia.

[7]  Anthony K. P. Jones,et al.  The cortical representation of pain , 1999, PAIN.

[8]  Jen-Chuen Hsieh,et al.  Central representation of chronic ongoing neuropathic pain studied by positron emission tomography , 1995, PAIN®.

[9]  F Träber,et al.  Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD , 2000, Neurology.

[10]  M. Fukumoto,et al.  Contralateral thalamic perfusion in patients with reflex sympathetic dystrophy syndrome , 1999, The Lancet.

[11]  S. Morikawa,et al.  Proton magnetic resonance spectroscopy with dementia. , 1993, Surgical neurology.

[12]  Karen Faith Berman,et al.  Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain , 1995, Pain.

[13]  Nikolaus M. Szeverenyi,et al.  Prefrontal cortical hyperactivity in patients with sympathetically mediated chronic pain , 2001, Neuroscience Letters.

[14]  S. Morikawa,et al.  Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. , 1999, Journal of neurosurgery.

[15]  R. Yezierski,et al.  Proton magnetic resonance spectroscopy of the thalamus in patients with chronic neuropathic pain after spinal cord injury. , 2002, AJNR. American journal of neuroradiology.

[16]  Jimmy D Bell,et al.  Proton MR spectroscopy in herpes simplex encephalitis: assessment of neuronal loss. , 1990, Journal of computer assisted tomography.

[17]  Dante R. Chialvo,et al.  Chronic pain patients are impaired on an emotional decision-making task , 2004, Pain.

[18]  Peter Kapeller,et al.  Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study , 2001, Journal of Neurology.

[19]  S. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[20]  G Helms,et al.  Analysis of 1.5 Tesla proton MR spectra of human brain using LCModel and an imported basis set. , 1999, Magnetic resonance imaging.